Search

Lung cancer has an uncanny ability to change its identity to resist drugs. Researchers are learning what drives these changes.

… Wednesday, July 7, 2021 When a person with lung cancer stops responding to a particular drug treatment, one possible reason is the cancer has morphed into a different subtype that is no longer sensitive to that drug. This phenomenon, known as lineage plasticity, is responsible for about 15% of cases

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce The Washington Post has named Vinod Balachandran, MD, surgeon-scientist and Director of The Olayan Center for Cancer Vaccines at MSK, to the inaugural edition of the Post Next 50, a list of up-and-coming changemakers shaping society in 2025.

… Tuesday, February 11, 2025 Post Next Logo Courtesy of the Washington Post Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce The Washington Post has named  Vinod Balachandran, MD, surgeon-scientist and Director of The Olayan Center for Cancer Vaccines at MSK, to the inaugural edition

Learn how people with cancer can protect themselves against foodborne illness.

… Monday, May 23, 2022 Foodborne illness (also known as food poisoning) is a special concern for people with cancer. Their immune systems are weaker than those of the general public, which makes it harder to fight off dangerous pathogens in foods that are undercooked, past their expiration date, or improperly

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2–6 in Chicago.

… Tuesday, May 30, 2023 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2

Performers from Hamilton, Company, Harry Potter and the Cursed Child, Carmen Jones and more bring MSK patients’ stories to life on March 22 and 29.

… Tuesday, March 16, 2021 Summary Performers from Hamilton , Company , Harry Potter and the Cursed Child , Carmen Jones and more bring MSK patients’ stories to life on March 22 and 29. On Monday, March 22 at 6:30 p.m. ET, with an encore performance at 9:00 p.m. , Visible Ink will present Act One of its

Gerstner Sloan Kettering student research has been recognized with the Grayer Fellowships, the Catell Fellowship, the Olayan Fellowship, the Palestin Fellowship, and the Geoffrey Beene Graduate Student Fellowship.

… Friday, September 7, 2012 Grayer Fellows Third-year students Marta Kovatcheva and Yilong Zou have been named Grayer Fellows. The fellowships were established by Mr. and Mrs. Jonathan Grayer. Mr. Grayer is a member of the Gerstner Sloan Kettering Board of Trustees, the Memorial Sloan Kettering Cancer

Memorial Sloan Kettering Cancer Center researchers join with experts from international institutions to estimate the potential impact of scaling up the availability of treatment and imaging modalities on breast cancer survival globally, together with improvements in quality of care.

… Thursday, August 19, 2021 Female breast cancer is the most commonly diagnosed cancer in the world, with wide variations in reported survival by country. Women in low-income and middle-income countries (LMICs) in particular face several barriers to breast cancer services, including diagnostics and treatment

Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College have formed the pioneering Tri-Institutional Therapeutics Discovery Institute, Inc. and have partnered with Takeda Pharmaceutical Company, Ltd.

… Tuesday, October 1, 2013 Pioneering Collaboration with Research-Based Global Pharmaceutical Company to Conduct Early-Stage Drug Discovery New Powerhouse for Therapeutic Research Founded with $20 Million in Generous Support from Lewis Sanders and Howard Milstein Memorial Sloan Kettering Cancer Center,

A new study by researchers at Memorial Sloan Kettering Cancer Center finds that even the sickest cancer patients are willing and able to "self-report" symptoms using the Internet, thus supplying key data in real time to their healthcare providers.

… Thursday, November 29, 2007 Traditionally, clinicians have relied on information provided by cancer patients during their office visits as the primary means of assessing patients’ symptoms and side effects. However, potentially serious consequences could arise if important symptoms go unreported during

David A. Scheinberg has been elected a member of the prestigious Association of American Physicians (AAP).

… Friday, May 1, 2009 Summary David A. Scheinberg has been elected a member of the prestigious Association of American Physicians (AAP). David A. Scheinberg has been elected a member of the prestigious Association of American Physicians (AAP). Dr. Scheinberg is a physician-scientist involved in both basic